Fight Colorectal Cancer, shared on LinkedIn:
“We’re proud to see Andrea Dwyer and Peter Stanich, members of our Medical Advisory Board and Genetics and Family History Advisory Council, presenting ‘How We Did It’ at the CGA-IGC conference in Denver.
Alongside their fellow Advisory Council members and nearly 150 patient advocacy organizations, medical societies, and medical professionals, they led the successful petition for an ICD-10 code for Lynch syndrome.
As of October 1, 2026, the code is officially live, helping providers and researchers identify Lynch Syndrome earlier for better care and continued research.”
Lynch syndrome and colorectal cancer
Lynch syndrome is an inherited cancer predisposition disorder caused by pathogenic variants in genes responsible for DNA mismatch repair, including MLH1, MSH2, MSH6, PMS2, and EPCAM.
These genetic alterations impair the correction of DNA replication errors, increasing the risk of cancer development. Lynch syndrome is the most common inherited colorectal cancer syndrome and accounts for approximately 3% of newly diagnosed colorectal cancer cases. Affected individuals have a substantially increased lifetime risk of colorectal cancer, often developing it before age 50.
The syndrome is also associated with
- endometrial
- ovarian
- gastric
- other cancers.
You may also be interested in:
Six New Organizations Join the Colorectal Cancer Care Initiative – Fight Colorectal Cancer
NICHE-2: Long-Term Survival Outcomes With Neoadjuvant Immunotherapy in dMMR Colon Cancer
